MOH — authorised 20 July 2021
- Marketing authorisation holder: ALBIREO PHARMA INC
- Status: likely_approved
MOH authorised Bylvay on 20 July 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 20 July 2021.
ALBIREO PHARMA INC holds the UAE marketing authorisation.